Word

INTGENOME

Status

Dead

Status Code

404

Status Date

Wednesday, December 21, 2022

Serial Number

79129104

Registration Number

4423665

Registration Date

Tuesday, October 29, 2013

Mark Type

5000

Filing Date

Friday, December 21, 2012

Published for Opposition

Tuesday, August 13, 2013

Cancellation Date

Wednesday, December 21, 2022

Trademark Owner History

Genloci Biotechnologies Inc. - Original Registrant

Classifications

5 Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietary and nutritional supplements for medical use

1 Protein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purpose; chemical substances for analyses in laboratories, other than for medical or veterinary purposes, namely, reagents for chemical analyses, reagents for research purposes, chemicals, namely, buffer and standard solutions used in analytical chemistry; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes

42 Technical research in the field of medicines and technical pharmaceuticals research; technical project studies, namely, conducting of technical feasibility studies in field of medicines and pharmaceuticals; research and development of new products for others; research in the field of environmental protection; scientific laboratory services; product quality testing; chemist services; chemical research; bacteriological research; biological research

The mark consists of the stylized wording "INTGENOME".
INT GENOME
Color is not claimed as a feature of the mark.
The wording "INTGENOME" has no meaning in a foreign language.

Trademark Events

Jul 20, 2023

Notification Of Effect Of Cancellation Of Intl Reg Mailed

Jul 20, 2023

Death Of International Registration

Mar 6, 2022

Total Invalidation Processed By The Ib

Feb 9, 2022

Total Invalidation Of Reg Ext Protection Sent To Ib

Feb 9, 2022

Invalidation Processed

Oct 26, 2021

Total Invalidation Of Reg Ext Protection Created

Feb 26, 2021

Cancelled Section 71

Feb 22, 2014

Final Decision Transaction Processed By Ib

Jan 31, 2014

Final Disposition Notice Sent To Ib

Jan 31, 2014

Final Disposition Processed

Jan 29, 2014

Final Disposition Notice Created, To Be Sent To Ib

Oct 29, 2013

Registered-Principal Register

Aug 13, 2013

Published For Opposition

Jul 24, 2013

Notice Of Publication

Jul 5, 2013

Law Office Publication Review Completed

Jun 25, 2013

Assigned To Lie

Jun 7, 2013

Approved For Pub - Principal Register

Jun 6, 2013

Teas/Email Correspondence Entered

Jun 5, 2013

Correspondence Received In Law Office

Jun 5, 2013

Teas Response To Office Action Received

Jun 5, 2013

Refusal Processed By Ib

May 18, 2013

Application Filing Receipt Mailed

May 16, 2013

Non-Final Action Mailed - Refusal Sent To Ib

May 16, 2013

Refusal Processed By Mpu

May 16, 2013

Non-Final Action (Ib Refusal) Prepared For Review

May 15, 2013

Non-Final Action Written

May 14, 2013

Assigned To Examiner

May 14, 2013

New Application Office Supplied Data Entered

May 13, 2013

Limitation From Original Application Entered

May 9, 2013

Sn Assigned For Sect 66a Appl From Ib